Costco has concluded an agreement with the manufacturer of the NOVO Nordisk drug to make anti-live drugs GLP-1, such as Ozempic and Wegovy, affordable for its members at about half the usual cost.
As part of the store recipe program, participants with a valid recipe can buy a four -week injection supply for $ 499. The offer is available only to those who pay from the pocket, since many insurers still do not cover these medicines.
This step takes place because the prices for drugs GLP-1 have risen, since the offer is still becoming increasingly limited. This forced some people to look for cheaper, compiled versions, a tendency that caused calls for more rigid federal supervision.
“We want to make sure that we offer real, genuine Wegovy and Ozempic, where patients seek medical help,” said David Moore, US President Novy Nordisk, USA. NBC NewsField
Both Overpick and Vegovy contain semi -unlutis, an injection medicine used to treat type 2 diabetes and promote weight loss. Semglutid works, imitating a natural hormone, known as a glucagono-like peptide 1 (GLP-1), which helps regulate the production of appetite and insulin. Reducing hunger, this can lead to significant weight loss.
Public acquaintance with drugs quickly grew. A survey The conducted in August discovered that more than 80% of the Americans heard at least “a little” about Semaglutid, while about one third they either tried it or expressed interest in this.
New Nordisk said that more than 200,000 Wegovy recipes are filled in the United States every week. Nevertheless, the company is faced with rigid competition from pharmacies and clinics selling cheaper compounds for GLP-1 drugs.
As of August 2025 12% Of the Americans, GLP-1 medicines were used for weight loss, including about the fifth women aged 50 to 64 years.
Costco entry into the GLP-1 market can further increase access and demand, especially considering that many medical care plans continue to deny drug insurance.
